title: Do intravenous immunoglobulin products manufactured from plasma collected in Italy place immunocompromised patients at risk of contracting human herpesvirus 8?
authors.forename: K
authors.initials: K
authors.lastname: Cristiano
authors.forename: M
authors.initials: M
authors.lastname: Wirz
authors.forename: G
authors.initials: G
authors.lastname: Gentili
mesh_terms: D001782:Blood Donors; D006566:Herpesviridae Infections / Q000453:epidemiology* / Q000209:etiology / Q000276:immunology; D019288:Herpesvirus 8, Human; D006801:Humans; D016867:Immunocompromised Host; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects; D007558:Italy; D012307:Risk Factors
chemical_list: D016756:Immunoglobulins, Intravenous